Metoprolol Pregnancy and Breastfeeding Warnings
Brand names: Kapspargo Sprinkle, Lopressor, Metoprolol Succinate ER, Metoprolol Tartrate, Toprol-XL
Metoprolol Pregnancy Warnings
Safety has not been established during pregnancy.
-According to some authorities: Use is not recommended unless benefit outweighs risk; if used during pregnancy, administer the lowest possible dose and discontinue at least 2 to 3 days prior to expected delivery, if possible.
AU TGA pregnancy category: C
US FDA pregnancy category: Not assigned
Risk summary: Inconclusive data available on the use of this drug in pregnant women to inform a drug-related risk.
Comments:
-Based on published literature, this drug may cause erectile dysfunction and inhibit sperm motility.
Animal studies have revealed increased post-implantation loss, fetolethality, and decreased neonatal survival. This drug crosses placenta, neonates born to mothers who are receiving metoprolol during pregnancy, may be at risk for hypotension, hypoglycemia, bradycardia, and respiratory depression.
AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.
Metoprolol Breastfeeding Warnings
AU and UK: Use is not recommended unless benefit outweighs risk.
US: This drug has been used without apparent harmful effects; caution is recommended.
Excreted into human milk: Yes (in small amounts)
Comments: This drug has been used without apparent harmful effects in the nursing infant.
An infant consuming 1 L of breast milk a day would receive a dose of less than 1 mg of drug.
See also
References for pregnancy information
- (2001) "Product Information. Lopressor (metoprolol)." Novartis Pharmaceuticals
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
- (2023) "Product Information. Kapspargo Sprinkle (metoprolol)." Sun Pharmaceutical Industries
- (2023) "Product Information. Toprol-XL (metoprolol)." Melinta Therapeutics, Inc.
- (2025) "Product Information. Lopressor (metoprolol)." Validus Pharmaceuticals LLC
- (2025) "Product Information. Metoprolol Tartrate (metoprolol)." Hikma USA (formerly West-Ward Pharmaceutical Corporation)
References for breastfeeding information
- (2001) "Product Information. Lopressor (metoprolol)." Novartis Pharmaceuticals
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.